Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, (18)F-FDG PET/MRI and CA 19–9

BACKGROUND: CT prediction of resectability and prognosis following neoadjuvant treatment (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) remains challenging. This study aims to determine whether addition of (18)F-fluorodeoxyglucose (FDG) postiron emission tomography (PET)/MRI and carb...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jeongin, Lee, Jeong Min, Joo, Ijin, Lee, Dong Ho, Yoon, Jeong Hee, Yu, Mi Hye, Jang, Jin-Young, Lee, Sang Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201764/
https://www.ncbi.nlm.nih.gov/pubmed/37217958
http://dx.doi.org/10.1186/s40644-023-00565-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201764/
https://www.ncbi.nlm.nih.gov/pubmed/37217958
http://dx.doi.org/10.1186/s40644-023-00565-8

Ejemplares similares